Trial NCT05836571

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2023-03149
Secondary IDs: 001704 10556 NCI-2023-03149

Last trial update was posted on 2024-03-21

MeSH Interventions

Ipilimumab Nivolumab

MeSH Conditions

Chondrosarcoma Histiocytoma, Malignant Fibrous Leiomyosarcoma Liposarcoma Sarcoma

Other Conditions

Locally Advanced Extraskeletal Myxoid Chondrosarcoma Locally Advanced Leiomyosarcoma Locally Advanced Liposarcoma Locally Advanced Undifferentiated Pleomorphic Sarcoma Locally Advanced Unresectable Soft Tissue Sarcoma Metastatic Undifferentiated Pleomorphic Sarcoma

Stopping Reasons

Other - Administrative and regulatory issues.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID